Between 28 June and 17 September 2018, 27 cases of human West Nile virus infections were recorded in Austria; four cases of West Nile neuroinvasive disease, 11 cases of West Nile fever, six infections detected by blood donation screening and six imported cases. In addition, 18 cases of human Usutu virus infections (all blood donors) were recorded. This is the highest number of annual infections recorded in Austria since the introduction of both viruses.
Background
Transfusion of SARS‐CoV‐2 convalescent plasma is a promising treatment for severe COVID‐19 cases, with success of the intervention based on neutralizing antibody content. Measurement by serological correlates without biocontainment needs, and an understanding of donor characteristics that may allow for targeting of more potent donors would greatly facilitate effective collection.
Study design and methods
One hundred convalescent plasma units were characterized for functionally active SARS‐CoV‐2 neutralizing antibodies, as well as for SARS‐CoV‐2 binding antibodies, with the intention to establish a correlation between the functionally more relevant neutralization assay and the more accessible ELISA. Donor demographics such as COVID‐19 disease severity, age and sex were correlated with antibody titers.
Results
A mean neutralization titer 50% of 1:230 (range < 1:8 – 1:1765) was seen for the 100 convalescent plasma units, with highly significant (p < 0.0001), yet quantitatively limited (R
2
= 0.2830) correlation with results of the ELISA. Exclusion of units with particularly high titers (>1:500) from analysis improved correlation (R
2
= 0.5386). A tendency of higher titer plasma units from donors with increased disease severity, advanced age and of male sex was seen, yet the functional relevance of this difference is questionable.
Conclusion
The ELISA‐based correlation to neutralization titer enabled a threshold proposal that could be used to eliminate lower titer units from the clinical supply for COVID‐19 treatment. Disease severity may be associated with the development of higher titers of neutralizing antibodies, although larger case numbers will be needed for additional confirmation.
This article is protected by copyright. All rights reserved.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.